-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TrpN5WIE7jAY0AanwSC9BnYe6SevUZhxnAhyyXuomg2xlxLlWNcG8wufw86rOr1l tu1oQ3H1L5eIbfAHJTvtJg== 0001082554-04-000010.txt : 20040206 0001082554-04-000010.hdr.sgml : 20040206 20040206094429 ACCESSION NUMBER: 0001082554-04-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040205 FILED AS OF DATE: 20040206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS CORP CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1110 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JEFFS ROGER CENTRAL INDEX KEY: 0001231615 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 04571851 BUSINESS ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORP STREET 2: 1110 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 4 1 primary_doc.xml PRIMARY DOCUMENT X0201 4 2004-02-05 0 0001082554 UNITED THERAPEUTICS CORP UTHR 0001231615 JEFFS ROGER 1 1 0 0 President & COO Common Stock 2004-02-05 2004-02-05 4 M 0 3500 12.69 A 17512 D Common Stock 2004-02-05 2004-02-05 4 S 0 3500 21.7386 D 14012 D Stock Options 12.69 2004-02-05 2004-02-05 4 M 0 3500 0 D 2000-05-01 2010-05-01 Common Stock 3500 476006 D The exercise of stock options and the corresponding sale of 3,500 shares of common stock (the "Shares") reported on this Form 4 are pursuant to the 10b5-1 Plan adopted by the Reporting Person on November 11, 2003. All proceeds from the sale of Shares after tax withholding will be applied toward payment of principal and interest of United Therapeutics' April 2002 loan to the Reporting Person to purchase his primary residence. /s/ Paul A. Mahon under Power of Attorney 2004-02-05 -----END PRIVACY-ENHANCED MESSAGE-----